Published in PLoS One on January 21, 2016
Trial Watch: Immunotherapy plus radiation therapy for oncological indications. Oncoimmunology (2016) 0.81
Correction: Immunological Characterization of Whole Tumour Lysate-Loaded Dendritic Cells for Cancer Immunotherapy. PLoS One (2016) 0.75
Dendritic cells and the control of immunity. Nature (1998) 56.54
PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol (2008) 19.24
RAS oncogenes: the first 30 years. Nat Rev Cancer (2003) 8.61
Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med (2001) 8.60
Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci U S A (1998) 6.82
Cancer immunotherapy via dendritic cells. Nat Rev Cancer (2012) 5.37
Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol (1998) 4.51
Dendritic cell immunotherapy: mapping the way. Nat Med (2004) 4.28
DC-based cancer vaccines. J Clin Invest (2007) 3.81
Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine. Cancer Res (2001) 3.01
Regulatory activity of autocrine IL-10 on dendritic cell functions. J Immunol (2001) 2.89
Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res (2003) 2.32
Interleukin-10 and the immune response against cancer: a counterpoint. J Leukoc Biol (2005) 2.24
Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells. Immunity (2000) 2.10
MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways. Oncogene (2000) 1.74
Cytokines and Immune Response in the Tumor Microenvironment. J Immunother (1991) (2001) 1.59
Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients. Clin Cancer Res (2003) 1.57
Antigens for cancer immunotherapy. Semin Immunol (2008) 1.46
Escape from immunotherapy: possible mechanisms that influence tumor regression/progression. Cancer Immunol Immunother (2004) 1.44
IFNgamma sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway. Oncogene (2002) 1.42
Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma. J Immunol (2003) 1.40
Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells. Int J Cancer (2000) 1.32
Regulation of dendritic cell recruitment by chemokines. Transplantation (2002) 1.31
Role of dendritic cells in the induction of regulatory T cells. Cell Biosci (2011) 1.27
Whole tumor antigen vaccines. Semin Immunol (2010) 1.19
CD83 expression on dendritic cells and T cells: correlation with effective immune responses. Eur J Immunol (2007) 1.15
The role of p21 in interferon gamma-mediated growth inhibition of human breast cancer cells. Cell Growth Differ (2000) 1.10
Evaluation of in vivo labelled dendritic cell migration in cancer patients. J Transl Med (2004) 1.08
The regulation of the development and function of dendritic cell subsets by GM-CSF: more than a hematopoietic growth factor. Mol Immunol (2012) 1.05
Chemokine mediated control of dendritic cell migration and function. Semin Immunol (2003) 1.04
Immunotherapy for human cancer using heat shock protein-peptide complexes. Curr Oncol Rep (2005) 1.03
Enhanced expression of heat shock proteins in gradually dying cells and their release from necrotically dead cells. Exp Cell Res (2005) 1.01
Tumor immunology: the glass is half full. Immunity (1998) 0.98
The Role of FcRn in Antigen Presentation. Front Immunol (2014) 0.93
The role of relB in regulating the adaptive immune response. Ann N Y Acad Sci (2003) 0.92
A CD91-positive subset of CD11c+ blood dendritic cells: characterization of the APC that functions to enhance adaptive immune responses against CD91-targeted antigens. J Immunol (2004) 0.92
CD4-8- dendritic cells prime CD4+ T regulatory 1 cells to suppress antitumor immunity. J Immunol (2005) 0.92
Dendritic cells (I): Biological functions. J R Coll Surg Edinb (2001) 0.86
Generation of dendritic cells from human bone marrow mononuclear cells: advantages for clinical application in comparison to peripheral blood monocyte derived cells. Int J Oncol (2002) 0.86
In vivo imaging of lymph node migration of MNP- and (111)In-labeled dendritic cells in a transgenic mouse model of breast cancer (MMTV-Ras). Mol Imaging Biol (2012) 0.84
Feeding dendritic cells with tumor antigens: self-service buffet or à la carte? Gene Ther (2000) 0.83
Therapeutic breast cancer vaccines: a new strategy for early-stage disease. BioDrugs (2009) 0.78